Global DNA and Gene Chip Market to Reach $20.5 Billion by 2030
The global market for DNA and Gene Chip estimated at US$8.4 Billion in the year 2022, is projected to reach a revised size of US$20.5 Billion by 2030, growing at a CAGR of 11.8% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 11.6% CAGR and reach US$12.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instrumentation segment is readjusted to a revised 12.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 16.4% CAGR
The DNA and Gene Chip market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 9.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.Select Competitors (Total 32 Featured) -
- Affymetrix Inc
- Agilent Technologies Inc.
- Applied Microarrays Inc.
- Arrayit Corp.
- Biomérieux SA
- Biometrix Technology Inc.
- Bioneer Corp.
- Canon Inc.
- Capitalbio Corp.
- Cytopathfinder Inc.
- Eurofins Mwg Operon
- Exiqon
- Genisphere LLC
- Greiner Bio-One
- Hitachi Ltd.
- Illumina Inc.
- Integrated Dna Technologies
- LC Sciences
- Life Technologies Corp.
- Lifegen Technologies
- Macrogen Inc.
- Microarrays Inc.
- NGK Insulators Ltd.
- Ocimum Biosolutions Ltd.
- Oxford Gene Technology
- Pamgene International B.V.
- Perkinelmer
- Promega Corp.
- Roche Nimblegen Inc.
- Samsung Electronics Co Ltd.
- Savyon Diagnostics Ltd.
- Scienion AG
- Sequenom Inc.
- Shanghai Biochip Co Ltd.
- Sigma-Aldrich
- Surmodics Inc.
- Thermo Fisher Scientific Inc.
- Toshiba Corp.
- Wafergen Biosystems Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affymetrix Inc
- Agilent Technologies Inc.
- Applied Microarrays Inc.
- Arrayit Corp.
- Biomérieux SA
- Biometrix Technology Inc.
- Bioneer Corp.
- Canon Inc.
- Capitalbio Corp.
- Cytopathfinder Inc.
- Eurofins Mwg Operon
- Exiqon
- Genisphere LLC
- Greiner Bio-One
- Hitachi Ltd.
- Illumina Inc.
- Integrated Dna Technologies
- LC Sciences
- Life Technologies Corp.
- Lifegen Technologies
- Macrogen Inc.
- Microarrays Inc.
- NGK Insulators Ltd.
- Ocimum Biosolutions Ltd.
- Oxford Gene Technology
- Pamgene International B.V.
- Perkinelmer
- Promega Corp.
- Roche Nimblegen Inc.
- Samsung Electronics Co Ltd.
- Savyon Diagnostics Ltd.
- Scienion AG
- Sequenom Inc.
- Shanghai Biochip Co Ltd.
- Sigma-Aldrich
- Surmodics Inc.
- Thermo Fisher Scientific Inc.
- Toshiba Corp.
- Wafergen Biosystems Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 88 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 8.4 Billion |
Forecasted Market Value ( USD | $ 20.5 Billion |
Compound Annual Growth Rate | 11.8% |
Regions Covered | Global |